12. November 2024 • News
For the last 18 years, Finance Day, organized by BIO Deutschland member Going Public, has been dedicated to startup-, growth- and capital market financing in the life sciences sector.
This year the event was held in Leipzig for the first time on October 24th and 25th. André Hofmann, Managing Director and CEO of biosaxony, and Markus Rieger, CEO of Going Public, welcomed around 150 participants to BIOCITY Leipzig. Presentations, discussion panels and startup pitches offered insights into the industry. Karin Hofelich, Head of Publishing Life Sciences, had invited BIO Deutschland to lead the panel discussion titled “How to…? Successful locals and flagships from all over Germany reveal their secrets to success”.
Anne-Kristin Heninger, Head of Operations, Founder and Managing Director of Seamless Therapeutics, Ben Orzelek, Senior Director, Head of Treasury & Investor Relations of ITM Isotope Technologies Munich, Jens Ruhe, COO and Founder of SciRhom, and Marc Struhalla, CEO and Founder of c-LEcta, spoke about their companies’ beginnings, their financing rounds, their business models, and their plans for the future. An entertaining evening event and a tour of the BIOCITY on the following day rounded off the program.
Founded in 1998, GoingPublic Media AG is a leading media company specializing in corporate finance and investment. The Group operates three cross-media platforms focusing on the capital market (GoingPublic capital market platform), family businesses/medium-sized companies (Entrepreneur edition platform, FuS trade magazine) and the life sciences (Life Sciences platform). GoingPublic Media AG (WKN 761210) is listed on the Quotation Board of the Frankfurt Stock Exchange (trading on Xetra) and in M:access, the SME segment of the Munich Stock Exchange.
Source (in German): www.biodeutschland.org
University Hospital Leipzig partnered with Apple to hold its first workshop on spatial computing for neurosurgeons in November 2024. The course offered insights into and hands-on practice with this latest technology.
cell-immune-gene-therapies
Small glas bottle which is normally used to store vaccine
Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications
digital-health
Human who looks onto a recording of brainwaves on his tablet computer and moves the model with his fingers
The Smart Infrastructure Hub Leipzig will receive a further 1,9 million euros from the cluster funding of the Saxon Ministry of Economic Affairs.
cell-immune-gene-therapies
Small glas bottle which is normally used to store vaccine
A relatively small metropolis in Germany’s Free State of Saxony – a dynamic hub for the life science industry? What was just a vision 20 years ago has become a reality for the city of Leipzig, which from October 24-26 co-hosted BIO-Europe, Europe’s largest annual biotech partnering event.
